v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Product revenue $ 101 $ 207
Costs of revenue 61 166
Gross profit 40 41
Operating expenses:    
Research and development 1,595 994
General and administrative 1,000 764
Sales and marketing 286 137
Total operating expenses 2,881 1,895
Loss from operations (2,841) (1,854)
Other income (expenses):    
Interest expense (1)
Interest income 47 104
Change in fair value of derivative liabilities (242) 4,166
Offering costs associated with warrant derivatives (1,246)
Forgiveness of PPP loan 391
Other income (net) 12
Total other income, net 208 3,023
Net income (loss) before income taxes (2,633) 1,169
Provision for income taxes
Net income (loss) (2,633) 1,169
Deemed dividend related to the beneficial conversion feature and accretion of a discount on preferred stock (9,284)
Net loss attributable to common stockholders $ (2,633) $ (8,115)
Net loss per share - basic and diluted    
Basic - net income (loss) $ (0.11) $ 0.19
Basic - deemed dividend and accretion of a discount on conversion of preferred stock (1.54)
Basic - attributable to common stockholders (0.11) (1.35)
Diluted - loss (0.11) (0.37)
Diluted - deemed dividend and accretion of a discount on conversion of preferred stock (1.16)
Diluted - attributable to common stockholders $ (0.11) $ (1.53)
Weighted average common shares outstanding:    
Basic 24,668,106 6,020,889
Diluted 24,668,106 8,035,392

Source